| Compound |
Company |
Primary Therapeutical Area / Indication |
Drug development |
|
| Balaglitazone |
|
Nutritional and Metabolic Diseases / Diabetes Mellitus, Type 2 |
Phase III
|
 |
|
|
| Liraglutide |
|
Nutritional and Metabolic Diseases / Diabetes Mellitus, Type 2 |
Phase III
|
 |
|
|
| Lixisenatide, Lyxumia® |
|
Nutritional and Metabolic Diseases / Diabetes Mellitus, Type 2 |
Phase III
|
 |
|
|
| Tesofensine |
|
Nutritional and Metabolic Diseases / Obesity |
Phase III
|
 |
|
|
| LCP-AtorFen |
Veloxis Pharmaceuticals A/S
|
Nutritional and Metabolic Diseases / Dyslipidemias |
Phase II
|
 |
|
|
| LixiLan |
|
Nutritional and Metabolic Diseases / Diabetes Mellitus, Type 2 |
Phase II
|
 |
|
|
| Semaglutide |
|
Nutritional and Metabolic Diseases / Diabetes Mellitus, Type 2 |
Phase II
|
 |
|
|
| NN1952 |
|
Nutritional and Metabolic Diseases / Diabetes Mellitus |
Phase I
|
 |
|
|
| NN9161 |
|
Nutritional and Metabolic Diseases / Obesity |
Phase I
|
 |
|
|
| NN9925 |
|
Nutritional and Metabolic Diseases / Diabetes Mellitus, Type 2 |
Phase I
|
 |
|
|
| PRC-4016 |
Pronova Biopharma Denmark
|
Nutritional and Metabolic Diseases / Dyslipidemias |
Phase I
|
 |
|
|
| SPC4955 |
|
Nutritional and Metabolic Diseases / Hypercholesterolemia |
Phase I
|
 |
|
|
| TM38837 |
|
Nutritional and Metabolic Diseases / Obesity |
Phase I
|
 |
|
|
| ZP2929 |
|
Nutritional and Metabolic Diseases / Diabetes Mellitus, Type 2 |
Phase I
|
 |
|
|
| 2hydroxyoleic acid |
Bridge BioResearch
|
Nutritional and Metabolic Diseases / Obesity |
Pre-clinical
|
 |
|
|
| CAM2036 |
|
Nutritional and Metabolic Diseases / Diabetes Mellitus, Type 2 |
Pre-clinical
|
 |
|
|
| Isosteviol |
Bridge BioResearch
|
Nutritional and Metabolic Diseases / Diabetes Mellitus, Type 2 |
Pre-clinical
|
 |
|
|
| Orph-001 |
Orphazyme
|
Nutritional and Metabolic Diseases / Lysosomal Storage Diseases |
Pre-clinical
|
 |
|
|
| PCSK9 |
|
Nutritional and Metabolic Diseases / Hyperlipidemias |
Pre-clinical
|
 |
|
|
| TransCon Hydrogel GLP-1 |
Ascendis Pharma A/S
|
Nutritional and Metabolic Diseases / Diabetes Mellitus, Type 2 |
Pre-clinical
|
 |
|
|